Autoantibodies

Displaying 1 - 7 of 7CSV
Rosain, J., Le Voyer, T., Liu, X., Gervais, A., Polivka, L., Cederholm, A., Berteloot, L., Parent, A. V., Pescatore, A., Spinosa, E., Minic, S., Kiszewski, A. E., Tsumura, M., Thibault, C., Esnaola Azcoiti, M., Martinovic, J., Philippot, Q., Khan, T., Marchal, A., … Casanova, J.-L. (2024). Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases. Journal of Experimental Medicine, 221(11). https://doi.org/10.1084/jem.20231152
Publication Date
Fleischer, S., Nash, T. R., Tamargo, M. A., Lock, R. I., Venturini, G., Morsink, M., Graney, P. L., Li, V., Lamberti, M. J., Liberman, M., Kim, Y., Tavakol, D. N., Zhuang, R. Z., Whitehead, J., Friedman, R. A., Soni, R. K., Seidman, J. G., Seidman, C. E., Geraldino-Pardilla, L., … Vunjak-Novakovic, G. (2024). An engineered human cardiac tissue model reveals contributions of systemic lupus erythematosus autoantibodies to myocardial injury. Nature Cardiovascular Research, 3(9), 1123–1139. https://doi.org/10.1038/s44161-024-00525-w
Publication Date
Rada, A., Hagemann, A., Aaberg Poulsen, C., Baumgartner, T., Berki, T., Blaabjerg, M., Brenner, J., Britton, J. W., Christiana, A., Ciano-Petersen, N. L., Crijnen, Y., Elišák, M., Farina, A., Friedman, A. R., Hayden, Z., Hébert, J., Holtkamp, M., Hong, Z., Honnorat, J., … Specht, U. (2024). Risk of Seizure Recurrence Due to Autoimmune Encephalitis With NMDAR, LGI1, CASPR2, and GABA B R Antibodies. Neurology Neuroimmunology & Neuroinflammation, 11(4). https://doi.org/10.1212/nxi.0000000000200225
Publication Date
Krustev, E., Hanly, J. G., Chin, R., Buhler, K. A., Urowitz, M. B., Gordon, C., Bae, S.-C., Romero-Diaz, J., Sánchez-Guerrero, J., Bernatsky, S., Wallace, D. J., Isenberg, D., Rahman, A., Merrill, J. T., Fortin, P. R., Gladman, D. D., Bruce, I. N., Petri, M. A., Ginzler, E. M., … Choi, M. Y. (2024). Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus. Lupus Science & Medicine, 11(1), e001139. https://doi.org/10.1136/lupus-2023-001139
Publication Date
Yandamuri, S. S., Filipek, B., Lele, N., Cohen, I., Bennett, J. L., Nowak, R. J., Sotirchos, E. S., Longbrake, E. E., Mace, E. M., & O’Connor, K. C. (2024). A Noncanonical CD56dimCD16dim/− NK Cell Subset Indicative of Prior Cytotoxic Activity Is Elevated in Patients with Autoantibody-Mediated Neurologic Diseases. The Journal of Immunology, 212(5), 785–800. https://doi.org/10.4049/jimmunol.2300015
Publication Date
Watts, A. J. B., Keller, K. H., Lerner, G., Rosales, I., Collins, A. B., Sekulic, M., Waikar, S. S., Chandraker, A., Riella, L. V., Alexander, M. P., Troost, J. P., Chen, J., Fermin, D., Yee, J. L., Sampson, M. G., Beck, L. H., Henderson, J. M., Greka, A., Rennke, H. G., & Weins, A. (2022). Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology. Journal of the American Society of Nephrology, 33(1), 238–252. https://doi.org/10.1681/asn.2021060794
Publication Date
Epstein, S. E., Levin, S., Onomichi, K., Langston, C., Yeshokumar, A., Fabian, M., Sand, I. K., Klineova, S., Lublin, F., Dykstra, K., Xia, Z., De Jager, P., Levine, L., Farber, R., Riley, C., & Vargas, W. S. (2021). Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapses. Multiple Sclerosis and Related Disorders, 56, 103229. https://doi.org/10.1016/j.msard.2021.103229
Publication Date